Clinical trial
Stereotactic Radiotherapy (SRT) Liver (COLD 1)
NCT00152906 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00152906 |
|---|---|
| Title | Stereotactic Radiotherapy (SRT) Liver (COLD 1) |
| Official title | Phase I/II Trial of Highly Conformal Radiotherapy for Unresectable Liver Metastases and Hepatobiliary Carcinoma |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | American Society of Clinical Oncology |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Liver Neoplasms, Neoplasm Metastases |
| Intervention type | Procedure |
| Interventions | Stereotactic radiotherapy (SRT) or highly conformal (CRT) |
| Enrollment | 140 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2016 |
| Completion | Jul 10, 2020 |
| First posted | Sep 9, 2005 |
| Last update posted | Aug 14, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: